BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38530465)

  • 1. Multidrug-resistant organism bloodstream infection and hospital acquisition among inpatients in three tertiary Greek hospitals during the COVID-19 era.
    Karakosta P; Vourli S; Kousouli E; Meletis G; Tychala A; Louka C; Vasilakopoulou A; Protonotariou E; Mamali V; Zarkotou O; Skoura L; Pournaras S
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1241-1246. PubMed ID: 38530465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.
    Polly M; de Almeida BL; Lennon RP; Cortês MF; Costa SF; Guimarães T
    Am J Infect Control; 2022 Jan; 50(1):32-38. PubMed ID: 34562526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world experience of how chlorhexidine bathing affects the acquisition and incidence of vancomycin-resistant enterococci (VRE) in a medical intensive care unit with VRE endemicity: a prospective interrupted time-series study.
    Suh JW; Kim NH; Lee MJ; Lee SE; Chun BC; Lee CK; Lee J; Kim JH; Kim SB; Yoon YK; Sohn JW; Kim MJ
    Antimicrob Resist Infect Control; 2021 Nov; 10(1):160. PubMed ID: 34758880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.
    Howard-Anderson JR; Gottlieb LB; Beekmann SE; Polgreen PM; Jacob JT; Uslan DZ
    Infect Control Hosp Epidemiol; 2024 Jun; 45(6):703-708. PubMed ID: 38351872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of deduplication on the detection rates of multidrug-resistant organism (MDRO) in various specimens: insights from the hospital infection surveillance program.
    Li Z; Zhu D; Ma X; Zang F; Zhang W; Luo C; Zhu C; Chen W; Zhu P
    Antimicrob Resist Infect Control; 2024 May; 13(1):54. PubMed ID: 38769515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interface between COVID-19 and bacterial healthcare-associated infections.
    O'Toole RF
    Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic burden of bacteremia due to multidrug-resistant organisms in Korea: a prospective case control study.
    Song KH; Kim CJ; Choi NK; Ahn J; Choe PG; Park WB; Kim NJ; Choi HJ; Bae JY; Kim ES; Lee H; Park JS; Jung Y; Lee SS; Park KH; Jung SI; Kim YS; Bang JH; Lee S; Kang YM; Kwak YG; Kim HB;
    J Glob Antimicrob Resist; 2022 Dec; 31():379-385. PubMed ID: 36400408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?
    Freire MP; Song ATW; Oshiro ICV; Andraus W; D'Albuquerque LAC; Abdala E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115220. PubMed ID: 33045498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.
    Kousouli E; Zarkotou O; Politi L; Polimeri K; Vrioni G; Themeli-Digalaki K; Tsakris A; Pournaras S
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):43-50. PubMed ID: 28879405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and mortality rate following antimicrobial-resistant bloodstream infections in tertiary-care hospitals compared with secondary-care hospitals.
    Lim C; Hantrakun V; Klaytong P; Rangsiwutisak C; Tangwangvivat R; Phiancharoen C; Doung-Ngern P; Kripattanapong S; Hinjoy S; Yingyong T; Rojanawiwat A; Unahalekhaka A; Kamjumphol W; Khobanan K; Leethongdee P; Lorchirachoonkul N; Khusuwan S; Siriboon S; Chamnan P; Vijitleela A; Fongthong T; Noiprapai K; Boonyarit P; Srisuphan V; Sartorius B; Stelling J; Turner P; Day NPJ; Limmathurotsakul D
    PLoS One; 2024; 19(5):e0303132. PubMed ID: 38768224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.
    Burton DC; Edwards JR; Horan TC; Jernigan JA; Fridkin SK
    JAMA; 2009 Feb; 301(7):727-36. PubMed ID: 19224749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the clinical significance of co-colonization of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in the intestinal tracts of patients in intensive care units: a case-control study.
    Yoon YK; Lee MJ; Ju Y; Lee SE; Yang KS; Sohn JW; Kim MJ
    Ann Clin Microbiol Antimicrob; 2019 Oct; 18(1):28. PubMed ID: 31601221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central-line-associated bloodstream infections, multi-drug-resistant bacteraemias and infection control interventions: a 6-year time-series analysis in a tertiary care hospital in Greece.
    Papanikolopoulou A; Maltezou HC; Gargalianos-Kakolyris P; Michou I; Kalofissoudis Y; Moussas N; Pantazis N; Kotteas E; Syrigos KN; Pantos C; Tountas Y; Tsakris A; Kantzanou M
    J Hosp Infect; 2022 May; 123():27-33. PubMed ID: 35149172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
    Cleland H; Tracy LM; Padiglione A; Stewardson AJ
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance among major pathogens causing healthcare-associated infection.
    Chang HC; Chang CH; Tien KL; Tai CH; Lin LM; Lee TF; Ku SC; Fang CT; Chen YC; Sheng WH
    J Formos Med Assoc; 2024 Jan; 123(1):123-132. PubMed ID: 37451958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms.
    Çaǧlayan Ç; Barnes SL; Pineles LL; Harris AD; Klein EY
    Front Public Health; 2022; 10():853757. PubMed ID: 35372195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
    Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Survey of Practices to Prevent Methicillin-Resistant Staphylococcus aureus and Multidrug-Resistant Acinetobacter baumannii in Thailand.
    Apisarnthanarak A; Ratz D; Khawcharoenporn T; Patel PK; Weber DJ; Saint S; Greene MT
    Clin Infect Dis; 2017 May; 64(suppl_2):S161-S166. PubMed ID: 28475783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.